Insurance, Prior Authorization & Cost Strategies for GLP-1 Therapy
Navigating insurance coverage for GLP-1 medications can be complex. This guide covers prior authorization, appeal strategies, coupon stacking, and manufacturer assistance programs.
Browse all clinician profiles in our reviewer directory.
Freshness status: Fresh (49 days since review)
Clinical change log
Substantive medical-content updates are tracked here for transparency. See our methodology and disclosures.
What changed:Updated clinical guidance language, risk/safety framing, and care-escalation instructions to align with current evidence standards.
Source impact:Primary references were reviewed and retained/updated where needed; claim-to-source traceability preserved.
Search Learn Guides
The Current Insurance Landscape
GLP-1 medication coverage varies dramatically between insurance plans, and the landscape is changing rapidly. As of early 2026, most commercial insurance plans cover FDA-approved GLP-1 medications for patients who meet specific clinical criteria, but coverage is far from universal.[1] What is typically covered: FDA-approved semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are covered by many commercial plans when prescribed for their FDA-approved indications — type 2 diabetes for Ozempic/Mounjaro and chronic weight management for Wegovy/Zepbound. Medicare Part D covers GLP-1 medications for diabetes but generally does not cover them for weight loss alone.[2] What is usually not covered: Compounded versions of GLP-1 medications are not covered by insurance because they are not FDA-approved. Off-label prescribing (e.g., using Ozempic for weight loss) may also face coverage denials. Some plans have explicit exclusions for obesity medications regardless of FDA approval status. The average out-of-pocket cost for branded GLP-1 medications without insurance ranges from $900 to $1,200 per month. This is why many patients turn to compounded alternatives through telehealth providers, where monthly costs typically range from $149 to $249.Understanding Prior Authorization
Prior authorization (PA) is a requirement by many insurance plans that your prescriber must obtain approval before the plan will cover a specific medication. For GLP-1 therapies, PA is extremely common and can add 3-14 days to the process of getting your first prescription filled. The typical PA process: Your prescriber submits a form to your insurance company documenting the medical necessity of GLP-1 therapy. This usually requires documentation of your BMI (typically 30+ or 27+ with comorbidities), previous weight-loss attempts, and relevant lab results (HbA1c, fasting glucose, lipid panel).[3] Step therapy: Many plans require you to try and fail cheaper alternatives before approving GLP-1 medications. This might include oral medications like metformin, phentermine, or orlistat. Document any previous attempts with dates and outcomes — this strengthens your PA request. Tips for faster approval: Have your prescriber include a letter of medical necessity. Include documentation of weight-related comorbidities (hypertension, sleep apnea, prediabetes). Request an expedited review if you have pressing clinical need. Follow up with the insurance company every 2-3 business days.Filing an Appeal if Denied
Insurance denials for GLP-1 therapy are common but often reversible. You have the right to appeal, and many initial denials are overturned on first appeal. First-level appeal: Request a formal appeal within the timeframe specified in your denial letter (usually 60 days for standard review, 72 hours for expedited). Your prescriber should submit additional supporting documentation addressing the specific reason for denial. Common denial reasons include insufficient documentation of BMI threshold, lack of documented prior treatments, or prescribing for an off-label indication.[4] Second-level appeal: If the first appeal is denied, you can request an independent external review. This is reviewed by an independent medical professional not affiliated with your insurance company. External reviews have a high overturn rate for GLP-1 denials when clinical criteria are clearly documented. Escalation tips: Enlist your prescriber to call the insurance medical director directly. Include peer-reviewed literature supporting GLP-1 therapy for your specific clinical situation. Document any adverse health outcomes caused by the delay in treatment. Consider involving a patient advocacy organization.Cost-Reduction Strategies
If insurance coverage is not available or the out-of-pocket cost remains too high, several strategies can reduce your monthly GLP-1 expense: Manufacturer savings cards: Both Novo Nordisk (Ozempic/Wegovy) and Eli Lilly (Mounjaro/Zepbound) offer commercial insurance savings cards that can reduce your copay to as little as $25/month for up to 12 months. These are not available to Medicare or Medicaid beneficiaries. Compounded alternatives: Compounded semaglutide and tirzepatide from 503B-certified pharmacies typically cost $149-$249/month. This is the route most patients take when insurance coverage is unavailable. See our provider comparison for pricing details. HSA/FSA accounts: GLP-1 medications prescribed for a diagnosed medical condition qualify as eligible medical expenses under most HSA and FSA plans. Keep your prescription documentation and receipts. Some telehealth providers, like Ro, explicitly accept HSA/FSA payment.[5] GoodRx and pharmacy discount cards: These can provide modest savings at retail pharmacies, though the discounts are usually not as significant as manufacturer savings cards or compounded alternatives. State assistance programs: Some states have programs that help residents afford prescription medications. Check with your state health department for available resources.Compare Providers Next
Compare options side by side on our GLP-1 provider scorecard, then review coverage workflow details on insurance support comparison. For provider-specific details, read our Ro review.
Payer-specific shortcuts: Aetna, BCBS, Cigna, and UnitedHealthcare.
Semaglutide pricing shortcuts: semaglutide cost, semaglutide cost per month, semaglutide injection cost, and compounded semaglutide cost.
Popular state-specific comparisons: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida .
References
- [1]Kaiser Family Foundation (KFF). Coverage of GLP-1 Drugs for Weight Loss Under Employer-Sponsored Insurance. June 2024. KFF
- [2]Centers for Medicare & Medicaid Services (CMS). Medicare Part D Coverage of Anti-Obesity Medications — Policy Update 2024. CMS.gov
- [3]American Medical Association (AMA). Prior Authorization and Step Therapy Requirements for GLP-1 Receptor Agonists. 2024. AMA
- [4]National Patient Advocate Foundation. Guide to Insurance Appeals for Prescription Medications. Updated 2025. NPAF
- [5]Internal Revenue Service (IRS). Publication 502 — Medical and Dental Expenses: HSA/FSA Eligibility for Prescription Medications. IRS Pub 502
Claim-to-Source Traceability
Reviewer attribution: Anika Reyes, MD
[1] What is typically covered: FDA-approved semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are covered by many commercial plans when prescribed for their FDA-approved indications — type 2 diabetes for Ozempic/Mounjaro and chronic weight man
Sources: [1]
[2] What is usually not covered: Compounded versions of GLP-1 medications are not covered by insurance because they are not FDA-approved.
Sources: [2]
[3] Step therapy: Many plans require you to try and fail cheaper alternatives before approving GLP-1 medications.
Sources: [3]
[4] Second-level appeal: If the first appeal is denied, you can request an independent external review.
Sources: [4]
[5] GoodRx and pharmacy discount cards: These can provide modest savings at retail pharmacies, though the discounts are usually not as significant as manufacturer savings cards or compounded alternatives.
Sources: [5]
Frequently Asked Questions
Does insurance cover compounded GLP-1?
No. Compounded medications are not FDA-approved and are not covered by any insurance plan. This is why patients using compounded GLP-1 through telehealth providers pay out of pocket, typically $149-$249/month depending on the provider and medication.
How long does prior authorization take for GLP-1?
Standard prior authorization review typically takes 5-14 business days. Expedited review (available for urgent clinical situations) takes 72 hours. Starting the PA process as early as possible and following up every 2-3 days can help prevent delays.
Can I use HSA or FSA funds for GLP-1 medications?
Yes. GLP-1 medications prescribed by a licensed prescriber for a diagnosed medical condition (obesity, type 2 diabetes, or prediabetes) are eligible HSA and FSA expenses. Keep your prescription, provider documentation, and payment receipts for tax purposes.